To Be Discontinued Injection Reproductive
Cetrorelix Acetate Injection · 302 days since initial FDA posting
Brand: CETRORELIX
FDA lists Cetrorelix Acetate Injection as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).
No availability text on this FDA row.
Cetrorelix Acetate Injection: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Cetrorelix Acetate Injection
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Injection
- Presentation
- Cetrorelix Acetate, Injection, Kit (NDC 0480-5795-08)
- Package NDC
- 0480-5795-08
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Nov 13, 2025
- Last Updated
- Nov 13, 2025
- Therapeutic Category
- Reproductive
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.